A B‐Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted therapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A B‐Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted therapies

Published:2022-01-19 Issue:4 Volume:11 Page:1232-1243
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Yao Kevin¹,Zhou Emily²,Cheng Chao³⁴⁵^ORCID

Affiliation:

1. Department of Electrical and Computer Engineering Texas A&M University College Station Texas USA

2. Department of Biosciences Rice University Houston Texas USA

3. Department of Medicine Baylor College of Medicine Houston Texas USA

4. Dan L Duncan Comprehensive Cancer Center Baylor College of Medicine Houston Texas USA

5. Institute for Clinical and Transcriptional Research Baylor College of Medicine Houston Texas USA

Funder

Cancer Prevention and Research Institute of Texas

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4491

Reference43 articles.

1. Cancer Statistics, 2021

2. The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases

3. Biology and treatment of BRAF mutant metastatic melanoma

4. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine

5. The role of BRAF V600 mutation in melanoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat);International Journal of Molecular Sciences;2023-05-23

2. Unveiling a BRAF Signature Proficient in Accurately Capturing Oncogenic Activity and Guiding Prognostic Prediction Across Multiple Cancers;2023

3. Biosensing chips for cancer diagnosis and treatment: a new wave towards clinical innovation;Cancer Cell International;2022-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3